Insider Transactions in Q2 2021 at Moderna, Inc. (MRNA)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 30
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
Jun 30
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$2,133,000
$237.0 P/Share
|
Jun 30
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,185,000
$237.0 P/Share
|
Jun 30
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$125,000
$25.93 P/Share
|
Jun 30
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,185,000
$237.0 P/Share
|
Jun 30
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
Jun 28
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,115,000
$223.0 P/Share
|
Jun 28
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
Jun 24
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.14%
|
$2,130,000
$213.78 P/Share
|
Jun 24
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.31%
|
$1,065,000
$213.78 P/Share
|
Jun 24
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.31%
|
$50,000
$10.9 P/Share
|
Jun 23
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
Jun 23
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,971,000
$219.65 P/Share
|
Jun 23
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.06%
|
$3,225,000
$215.08 P/Share
|
Jun 23
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+0.46%
|
$75,000
$5.95 P/Share
|
Jun 23
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,095,000
$219.65 P/Share
|
Jun 23
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$125,000
$25.93 P/Share
|
Jun 23
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,095,000
$219.65 P/Share
|
Jun 23
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
Jun 21
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,000,000
$200.86 P/Share
|
Jun 21
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
Jun 17
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.14%
|
$2,000,000
$200.0 P/Share
|
Jun 16
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
Jun 16
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,800,000
$200.0 P/Share
|
Jun 16
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,000,000
$200.0 P/Share
|
Jun 16
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
Jun 16
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,000,000
$200.0 P/Share
|
Jun 16
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$125,000
$25.93 P/Share
|
Jun 14
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,065,000
$213.32 P/Share
|
Jun 14
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
Jun 14
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-1.23%
|
$4,260,000
$213.32 P/Share
|
Jun 14
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+0.41%
|
$140,000
$7.6 P/Share
|
Jun 10
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.14%
|
$2,160,000
$216.7 P/Share
|
Jun 09
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
Jun 09
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,908,000
$212.3 P/Share
|
Jun 09
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,060,000
$212.3 P/Share
|
Jun 09
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
Jun 09
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,060,000
$212.3 P/Share
|
Jun 09
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$125,000
$25.93 P/Share
|
Jun 07
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,035,000
$207.04 P/Share
|
Jun 07
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
Jun 03
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.14%
|
$1,880,000
$188.89 P/Share
|
Jun 03
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.62%
|
$1,880,000
$188.89 P/Share
|
Jun 03
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.61%
|
$0
$0.99 P/Share
|
Jun 02
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.62%
|
$1,830,000
$183.9 P/Share
|
Jun 02
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.61%
|
$0
$0.99 P/Share
|
Jun 02
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$915,000
$183.9 P/Share
|
Jun 02
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$125,000
$25.93 P/Share
|
Jun 02
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
Jun 02
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,647,000
$183.9 P/Share
|